Stay updated with breaking news from Sean Leous. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Preclinical studies demonstrate vebreltinib is effective for a variety of tumor types carrying MET-driver alterations, and effective for overcoming MET-amplification dependent resistance to EGFR...
SAN DIEGO and LONDON, March 11, 2024 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) ('Conduit Pharmaceuticals' or 'Conduit') tod...
SAN DIEGO and LONDON, Jan. 31, 2024 -- Conduit Pharmaceuticals Inc. , a multi-asset, clinical-stage life science company delivering an efficient model for compound development, today announced CEO...
Abpro Announces Filing of Registration Statement on Form S-4 in Connection with Business Combination Agreement with Atlantic Coastal Acquisition Corp. II GlobeNewswire January 22, 2024 WOBURN, Mass. and NEW YORK, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Abpro Corporation (“Abpro”), a biotech company with the mission of improving the lives of mankind facing...
Apollomics has an initial 180-day period through July 15, 2024 to regain compliance with Minimum Bid Price RequirementFOSTER CITY, Calif., Jan. 19, 2024 -- Apollomics Inc. , a clinical-stage...